04.11.2019 • NewsElaine BurridgeUralchem

Uralchem in Angolan Fertilizer JV

Uralchem in Angolan Fertilizer JV (c) Singkham/Shutterstock
Uralchem in Angolan Fertilizer JV (c) Singkham/Shutterstock

Russia’s Uralchem has signed a Memorandum of Understanding (MoU) with Angolan company Grupo Opaia to jointly develop a fertilizer complex.

The companies intend to invest $1.2 billion to $1.3 billion to establish an ammonia and urea complex in Angola with startup planned for 2023. Output of the urea plant will be 1.2 million t/y.

Uralchem will be in charge of the design and construction of the plants along with marketing the output while Grupo Opaia will be responsible for securing permit approvals, gas supply and locating a site.

Dmitry Konyaev, deputy chairman of Uralchem’s board of directors, said the complex will be able to provide Angola and bordering countries with high-quality fertilizers.

 The companies signed the MoU during the Russia-Africa Economic Forum, which was held in Sochi, Russia, on Oct. 23-24. The primary aim of the forum is to create favorable trade and economic relations between the Russian Federation and African countries.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.